https://ke.news.prod.rtd.asu.edu/2021/12/08/oncomyx-closes-50-million-series-b-to-advance-a-novel-immuno-oncology-platform-that-delivers-multiple-cancer-killing-payloads/
OncoMyx closes $50 million series B to advance a novel immuno-oncology platform that delivers...
Apr 6, 2022 - The ASU Knowledge Enterprise is changing the way the world solves problems through solutions-focused research and innovation.